Medication use by adolescents and adults with fragile X syndrome.
Background The behavioural challenges and medical conditions associated with fragile X syndrome (FXS) can lead to increased need for medications. Method This longitudinal study examined the use of prescription medications for psychotropic and non-psychotropic purposes by adolescents and adults with...
| Published in: | Journal of Intellectual Disability Research Vol. 62; no. 2; pp. 94 - 106 |
|---|---|
| Main Authors: | , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Feb2018
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127554761&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 127554761 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09642633 EUL jtl: Journal of Intellectual Disability Research issn: 09642633 maglogo: Y pubinfo: dt: Feb2018 vid: 62 iid: 2 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 127554761 127554761 127554761 10.1111/jir.12433 127554761 ppf: 94 ppct: 12 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Medication use by adolescents and adults with fragile X syndrome. aug: au: Laxman, D. J. Greenberg, J. S. DaWalt, L. S. Hong, J. Aman, M. G. Mailick, M. affil: Department of Human Development and Family Studies, Utah State University, Logan UT, USA sug: subj: Drug Utilization Fragile X Syndrome In Adolescence Fragile X Syndrome In Adulthood Psychotropic Drugs Human Adolescence Adult Behavioral and Mental Disorders Diagnosis Female Adolescent: 13-18 years Adult: 19-44 years Female ab: Background The behavioural challenges and medical conditions associated with fragile X syndrome (FXS) can lead to increased need for medications. Method This longitudinal study examined the use of prescription medications for psychotropic and non-psychotropic purposes by adolescents and adults with FXS drawn from a North American community sample (N = 105). Odds and probabilities of continuing or discontinuing medication were calculated. Predictors of medication use were calculated. Results More than two-thirds took psychotropic medication, and about one-quarter took non-psychotropic medication. Over a 3-year period, those who initially took prescription medications were considerably more likely to remain on medications than to stop. Individuals with more autism symptoms, more behavioural problems, a mental health diagnosis, and greater family income were significantly more likely to use psychotropic medication 3 years later. Individuals who had more health problems, a mental health diagnosis, and were female were more likely to use non-psychotropic medication over this time period. Conclusions Findings highlight the elevated and ongoing use of medication by individuals with FXS. Implications for social and behavioural research on FXS are discussed. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|